Journal of Dermatological Treatment · 2018 · 29 citations · 4 references
MedicineDermatologyPharmacologyClinical PharmacologyDermatopathologyRheumatologyAtopic DermatitisAutoimmune Skin DiseasesTopical PreparationsAtopic Dermatitis AssociationAtopic Dermatitis PharmacotherapyPhosphodiesterase InhibitionPhosphodiesterase SignalingPhosphodiesterase-4 InhibitorsPsoriasis TherapyPsoriatic Disease
Crisaborole, a topical phosphodiesterase-4 (PDE4) inhibitor, is effective in patients with atopic dermatitis. As systemic PDE4 inhibition has also been used with success in psoriasis, clinical trials are underway to determine the utility of topical PDE4 inhibitors in these patients. However, there is no current literature documenting use of crisaborole for psoriasis. Here, we present two cases in which patients with psoriasis were treated successfully with crisaborole.
4
Kim Papp, Kristian Reich, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology · 2015 · 669 citations · Full text